Six NHS trusts in the West Midlands have launched a procurement process for a £290m regional sterile medicines manufacturing facility, intended to replace ageing aseptic production units currently operating across the region.
The regional sterile medicines, or aseptic, units are used to produce critical injectable medicines in a controlled, contamination-free environment.
The trusts involved are: University Hospitals Birmingham NHS Foundation Trust, University Hospitals Coventry and Warwickshire NHS Trust, Worcestershire Acute Hospitals NHS Trust, South Warwickshire NHS Foundation Trust, George Eliot Hospital NHS Trust, and Wye Valley NHS Trust.
According to a notice published on Find a Tender, the Trusts are seeking a commercial partner to design, build, commission, and operate a new MHRA-licensed sterile drugs production facility.
The facility will supply critical injectable medicines to all six trusts collectively, rather than operating as a single-trust service.
The contract is expected to run for an initial 10 years, with the option to extend to up to 15 years, and has an estimated total value of £290m including VAT.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Building Better Healthcare.
Subscribe now Already a subscriber? Sign in here.